Events Partner Content 14th Annual Pre-Filled Syringes and Drug Devices 2022 The Future of Drug Delivery and Combination Products
Partner Content Partner Content Regulatory Issues for PF Syringes & Injectable Drug Devi... Pre-Filled Syringes & Injectable Drug Devices Europe
Partner Content Partner Content Full Agenda Released for Pre-Filled Syringes & Injectabl... The Future of Drug Delivery & Combination products
Events Partner Content Pre-Filled Syringes & Injectable Drug Devices Europe SMi is proud to present their 11th annual European
News BioMarin ends year with $4.8bn play for Amicus BioMarin takes a leap towards its $4bn revenue target with a $4.8bn deal to acquire Amicus, which has two rare disease therapies on the market.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
